Valuation: EUROAPI

Market Cap 119M 136M 110M 102M 193M 13.03B 197M 1.32B 515M 6.38B 511M 500M 22.14B P/E 2026 *
-1.57x
P/E 2027 * -2.96x
Enterprise Value 77.7M 88.59M 71.74M 66.29M 126M 8.48B 128M 862M 335M 4.15B 333M 325M 14.41B EV / Sales 2026 *
0.1x
EV / Sales 2027 * 0.15x
Free-Float
65.03%
Yield 2026 *
-
Yield 2027 * -
1 day-0.71%
1 week-6.70%
Current month-5.71%
1 month-1.57%
3 months-1.63%
6 months-41.84%
Current year-44.59%
1 week 1.24
Extreme 1.238
1.38
1 month 1.23
Extreme 1.23
1.38
Current year 1.23
Extreme 1.23
2.26
1 year 1.23
Extreme 1.23
3.41
3 years 1.23
Extreme 1.23
12.96
5 years 1.23
Extreme 1.23
18.92
10 years 1.23
Extreme 1.23
18.92
Manager TitleAgeSince
Chief Executive Officer - 2024-12-08
Director of Finance/CFO - 2024-10-16
Compliance Officer - 2023-11-26
Director TitleAgeSince
Director/Board Member 62 2022-05-05
Director/Board Member - 2022-05-05
Chairman 57 2024-12-08
Change 5-day change 1-year change 3-year change Capi.($)
-0.71%-6.70% - - 136M
-1.60%+2.02%+56.34%+168.94% 1,084B
-1.44%+3.71%+69.07%+65.40% 634B
-0.75%+0.67%+33.18%+86.52% 447B
-0.40%-2.23%+28.42%+25.88% 330B
-8.91%-10.35%+25.79%+28.04% 295B
-0.62%-2.25%+28.28%+45.88% 285B
-0.88%-3.72%-27.85%-39.79% 218B
-0.03%+1.84%+23.90%+68.30% 199B
-0.40%+7.82%+22.29%+82.50% 169B
Average -1.33%+2.52%+28.83%+59.08% 406.65B
Weighted average by Cap. -0.91%+2.48%+40.21%+85.23%

Financials

2026 *2027 *
Net sales 760M 867M 702M 649M 1.23B 83.02B 1.25B 8.44B 3.28B 40.63B 3.26B 3.18B 141B 782M 891M 722M 667M 1.26B 85.32B 1.29B 8.67B 3.37B 41.75B 3.35B 3.27B 145B
Net income -75.7M -86.31M -69.89M -64.58M -122M -8.26B -125M -840M -326M -4.04B -324M -317M -14.04B -40.25M -45.89M -37.16M -34.34M -65.09M -4.39B -66.39M -447M -174M -2.15B -172M -169M -7.47B
Net Debt -41.66M -47.5M -38.46M -35.54M -67.37M -4.55B -68.72M -462M -180M -2.23B -178M -174M -7.73B -5.06M -5.77M -4.67M -4.32M -8.19M -553M -8.35M -56.2M -21.84M -271M -21.68M -21.2M -939M
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
26-07-09 1.254 -1.18% 0
26-07-08 €1.254 -2.03% 4,861
26-07-07 €1.280 -4.33% 1,871
26-07-06 €1.338 -1.18% 108,626
26-07-03 €1.354 +0.74% 256
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
1.254EUR
Average target price
1.475EUR
Spread / Average Target
+17.62%

Quarterly revenue - Rate of surprise